Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global central nervous system treatment market is expected to grow at a CAGR of 8.1% during the period 2024-2032. The market is likely to be driven by development of new treatment systems, regulations seeking to support treatment systems for central nervous system disorders, and technological innovations. North America, Europe and Asia are expected to be key markets.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The nervous system comprises central nervous system (CNS) (consisting of the brain and the spinal cord) and the peripheral nervous system (consisting of nerves, including the autonomic nervous system, outside of the brain and spinal cord, including those in the arms, legs, and trunk of the body). Together, the brain and the spinal cord act as the main "processing centre" for the entire nervous system, and control all the functions of the body.
Several different medical conditions could affect the nervous system, including degenerative diseases (including Alzheimer’s disease and Parkinson’s disease), blood vessel disorders in the brain (including arteriovenous malformations and cerebral aneurysms), tumours (benign and malignant), disorders of the pituitary gland, demyelinating diseases (such as multiple sclerosis), headaches (including migraines), epilepsy, head injuries like concussions and brain trauma, movement disorders (such as tremors and Parkinson’s disease), neuro-ophthalmologic diseases (vision problems as a result from damage to the optic nerve or its connections to the brain), peripheral nerve diseases (neuropathy), spine disorders, mental disorders (such as schizophrenia), infections (such as meningitis), stroke, etc.
Central nervous system disorders signify a key area of unmet medical need. Personalized medicine (PM) is a novel concept that seeks to capitalize on known variability in patients, which causes differences in disease susceptibility and response to medication. The European regulatory network seeks to facilitate the development of PM methods for central nervous system disorders, including biomarkers (BMs), companion diagnostics, pharmacogenomics, and rare diseases; new methodologies and innovative clinical trial designs; and advanced treatments and therapies (e.g. gene therapies, somatic cell therapies, and tissue-engineered medicines). Such developments are expected to drive the global central nervous system treatment market. Increased focus on patient centricity and participation of patient groups has led to enhanced regulatory backing, including devoted scientific advice resources, new guidance documents, and multistakeholder platforms to meet challenges in PM development. Such initiatives led to some success (e.g., BM qualification), and there is hope that these would facilitate future approval of personalized central nervous system medicines.
Neuroradiology (a branch of neuroscience medicine) seeks to diagnose and treat nervous system problems. Treatments include balloon angioplasty and stenting of carotid or vertebral artery; intra-arterial therapy for stroke; radiation oncology of the brain and spine; endovascular embolization and coiling to treat cerebral aneurysms; kyphoplasty and vertebroplasty to treat vertebral fractures; needle biopsies, spine and soft tissues; etc. Treatment may also include medicines [possibly administered by a drug pump (like those used for people with severe muscle spasms)], deep brain stimulation, spinal cord stimulation, rehabilitation/physical therapy after brain injury or stroke, spinal surgery, etc. Availability of treatment systems, along with that of health care providers, is expected to boost the global central nervous system treatment market. Health care providers from multiple specialties may be required to treat central nervous system related conditions. These may include neurologist, vascular surgeon, neurosurgeon, neuropsychologist, pain physician, psychiatrist, psychologist, radiologist, neuroscientist, nurse practitioners (NPs), physician assistants (PAs), nutritionists or dietitians, primary care doctors, physical therapists, occupational therapists, speech-language therapists, etc.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By type, the market is segmented into:
By drug class, the market is divided into:
By drug type, the market is classified into:
By region, the market is segmented into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global central nervous system treatment market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Disease Type |
|
Breakup by Drug Class |
|
Breakup by Drug Type |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global central nervous system treatment market is projected to grow at a CAGR of 8.1% between 2024 and 2032.
The major drivers of the market include the increasing geriatric population, launch of new prospective products and pipeline drugs, favourable reimbursement policies, and improving healthcare infrastructure.
Increasing incidence of neurological disorders and regulations seeking to support treatment systems for central nervous system disorders are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The different types of central nervous system treatment in the market are neurovascular diseases, neurodegenerative diseases, mental health, and infectious diseases, among others.
Based on drug class, the market is divided into immunomodulatory drugs, interferons, decarboxylase inhibitors, dopamine agonists, antidepressants, and analgesics, among others.
The various drug types in the market are biologics and non-biologics.
The major players in the industry are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., F. Hoffmann-La Roche Ltd, Otsuka Pharmaceutical Co., Ltd., and Angelini S.p.a., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share